Lakeland Financial Corporation is a bank holding company. The company has market cap of $1.05 billion. The Company, through its subsidiary, Lake City Bank , provides an array of services and products throughout its Northern and Central Indiana markets. It has a 20.63 P/E ratio. It offers commercial and consumer banking services, as well as trust and wealth management, brokerage, investment and treasury management commercial services.
About 129,716 shares traded. Jazz Pharmaceuticals plc – Ordinary Shares (NDAQ:JAZZ) has risen 11.42% since August 30, 2016 and is uptrending. It has outperformed by 3.30% the S&P500.
Monarch Capital Management Inc holds 3.97% of its portfolio in Lakeland Financial Corporation for 224,401 shares. Neumeier Poma Investment Counsel Llc owns 525,467 shares or 3.43% of their US portfolio. Moreover, Walthausen & Co. Llc has 1.21% invested in the company for 275,093 shares. The Indiana-based 1St Source Bank has invested 0.61% in the stock. Vaughan Nelson Investment Management L.P., a Texas-based fund reported 825,922 shares.
Since January 1, 0001, it had 5 insider purchases, and 7 selling transactions for $1.14 million activity.
Ratings analysis reveals 0 of Lakeland Financial’s analysts are positive. Out of 5 Wall Street analysts rating Lakeland Financial, 0 give it “Buy”, 0 “Sell” rating, while 5 recommend “Hold”. The lowest target is $32 while the high is $45. The stock’s average target of $32 is -24.21% below today’s ($42.22) share price. LKFN was included in 6 notes of analysts from July 28, 2015. Stephens downgraded the stock to “Equal-Weight” rating in Monday, June 13 report. The rating was downgraded by Raymond James on Thursday, December 17 to “Mkt Perform”. The company was downgraded on Tuesday, October 27 by FIG Partners. The firm has “Market Perform” rating by Wood given on Tuesday, August 9. DA Davidson initiated the stock with “Neutral” rating in Thursday, July 21 report.
It closed at $42.22 lastly. It is down 17.12% since August 30, 2016 and is uptrending. It has outperformed by 8.99% the S&P500.
Analysts await Lakeland Financial Corporation (NASDAQ:LKFN) to report earnings on April, 24. They expect $0.53 EPS, up 8.16% or $0.04 from last year’s $0.49 per share. LKFN’s profit will be $13.18M for 19.92 P/E if the $0.53 EPS becomes a reality. After $0.53 actual EPS reported by Lakeland Financial Corporation for the previous quarter, Wall Street now forecasts 0.00% EPS growth.
Investors sentiment decreased to 0.68 in 2016 Q4. Its down 0.13, from 0.81 in 2016Q3. It dropped, as 64 investors sold Jazz Pharmaceuticals plc – Ordinary Shares shares while 111 reduced holdings. 43 funds opened positions while 76 raised stakes. 50.81 million shares or 3.20% less from 52.49 million shares in 2016Q3 were reported. Rhenman & Asset Mgmt Ab reported 1.06% stake. Barclays Public Limited Liability stated it has 0.02% in Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ). Moreover, North Star Inv Mgmt Corp has 0% invested in Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ). Tiaa Cref Invest Ltd Company has 238,506 shares. Cg Asset Mngmt Ltd Liability accumulated 1.1% or 27,125 shares. Fmr Ltd Liability Co owns 7.47 million shares. Goldman Sachs Group Inc reported 372,343 shares. 25,749 are held by British Columbia Mgmt Corp. Vanguard Gru Incorporated holds 0.03% in Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) or 4.37 million shares. Somerset Com holds 0.21% or 3,185 shares in its portfolio. Calamos Advsrs Ltd Liability Company stated it has 207,932 shares or 0.18% of all its holdings. Dekabank Deutsche Girozentrale holds 0.06% or 55,156 shares in its portfolio. Rock Springs Capital Management L P owns 123,700 shares. Eqis Capital Management Inc reported 11,060 shares or 0.08% of all its holdings. Commonwealth Equity Svcs Inc has invested 0.01% in Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ).
Since October 17, 2016, it had 1 insider buy, and 9 selling transactions for $617,259 activity. $22,438 worth of Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) was sold by MILLER MICHAEL PATRICK. On Friday, November 11 O’Keefe Kenneth W bought $227,688 worth of Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) or 2,000 shares. $116,666 worth of Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) was sold by Treacy Paul. ENRIGHT PATRICK G also sold $68,919 worth of Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) shares. 4,000 shares were sold by Cox Russell J., worth $515,000.
